KALV

Insider Purchase: 10% owner at $KALV Buys 61,700 Shares

Healthcare Capital Partners III, L.P. Venrock, a 10% owner of $KALV, bought 61,700 shares of the company on 02-13-2025 for an estimated $575,661. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 1.2%. Following this trade, they now own 5,278,985 shares of this class of $KALV stock.

$KALV Insider Trading Activity

$KALV insiders have traded $KALV stock on the open market 20 times in the past 6 months. Of those trades, 8 have been purchases and 12 have been sales.

Here’s a breakdown of recent trading of $KALV stock by insiders over the last 6 months:

  • HEALTHCARE CAPITAL PARTNERS III, L.P. VENROCK has made 8 purchases buying 336,212 shares for an estimated $3,087,433 and 0 sales.
  • BENJAMIN L PALLEIKO (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 4 sales selling 43,594 shares for an estimated $468,047.
  • PAUL K. AUDHYA (CHIEF MEDICAL OFFICER) has made 0 purchases and 4 sales selling 20,372 shares for an estimated $218,607.
  • CHRISTOPHER YEA (CHIEF DEVELOPMENT OFFICER) has made 0 purchases and 4 sales selling 18,173 shares for an estimated $195,027.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$KALV Hedge Fund Activity

We have seen 69 institutional investors add shares of $KALV stock to their portfolio, and 52 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.


This article is not financial advice. See Quiver Quantitative's disclaimers for more information.


This article was originally published on Quiver News, read the full story.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.